This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by Richard Garfinkle & Marguerite Gorter during the Diverticulitis Consensus Conference on April 12 2018
Keyword(s): 5-ASA, abscess, age, Annals of Surgery, antibiotic therapy, AVOD trial, C-reactive protein, colonic evaluation, complications, counseling, CRP, CT scan, diagnosis, discharge, disease severity, DIVER trial, Dutch, Europe, fever, fiber, fistula, gastrointestinal symptoms, high level data, high risk, hospital admissions, Iceland, immunocompetent, interval endoscopy, invasive carcinoma, long-term treatment, malignancy, mass, mortality, non-operative management, non-resection management, North America, observational studies, outpatient therapy, pain, prospective studies, QoL, quality of life, randomized controlled trials, RCTs, readmission, recommendations, recovery, recurrent diverticulitis, regular diet, risk factor modification, risk factors, safety, screening colonoscopy, Spain, stricture, survey, symptomatic, systematic review, treatment failure, uncomplicated diverticulitis
Question 3.1: What are the risk factors for developing recurrent or ongoing diverticulitis among patients with uncomplicated acute diverticulits?–54 sec
Question 3.2: What are the optimal non-operative strategies in the management of uncomplicated acute diverticulitis?–1:41
Citations–2:46 Br J Surg 2012
Citations–7:31 Ann Surg 2014
Eur J Gastroenterol Hepatol 2013
Question 3.3: What is the optimal follow-up following uncomplicated acute diverticulitis?–10:38
Question 3.4: What is the role of interval endoscopy following an acute episode of diverticulitis?–11:30
Citations–12:23 Ann Surg 2014